KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating...

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Programmed death-ligand 1 (PD-L1) is a key immune checkpoint molecule that suppresses anti-tumor immunity.
• Radiation therapy can enhance PD-L1 expression on tumor cells, potentially limiting its therapeutic efficacy.
• Karyopherin-β1 (KPNB1) has been implicated in radiation-induced PD-L1 upregulation in head-and-neck squamous cell carcinoma.

Purpose of the Study:

• To elucidate the molecular mechanisms by which KPNB1 mediates radiation-induced PD-L1 expression.
• To investigate the role of the transcription factor interferon regulatory factor 1 (IRF1) in this process.

Main Methods:

• Western blot analysis to assess protein expression levels of IRF1 and PD-L1.
• Flow cytometry to quantify cell surface PD-L1 expression.
• IRF1 knockdown experiments to determine its necessity for PD-L1 regulation.
• Immunofluorescence and western blot analysis using a KPNB1 inhibitor (importazole).

Main Results:

• Radiation significantly increased IRF1 expression.
• IRF1 knockdown reduced PD-L1 expression on irradiated cells, but not non-irradiated cells.
• Inhibition of KPNB1 by importazole reduced IRF1 nuclear localization and its upregulation post-irradiation.
• KPNB1 inhibition attenuated the radiation-induced increase in cell surface PD-L1 expression.

Conclusions:

• Upregulation and nuclear import of IRF1 are critical for radiation-induced PD-L1 expression.
• KPNB1 plays a crucial role in mediating radiation-increased PD-L1 expression through IRF1.
• These findings provide mechanistic insights into immune evasion strategies employed by tumors post-radiation.